Clinical Trial: Schistosoma Haematobium Infections and Praziquantel
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Schistosoma Haematobium Infections Among Schoolchildren in Central Sudan One Year After Treatment With Praziquantel
Brief Summary: The purpose of this study is to evaluate the impact of praziquantel for the treatment of Schistosoma haematobium infection among schoolchildren in Al Salamania in Central Sudan.
Detailed Summary: A longitudinal study will be conducted to evaluate the impact of praziquantel for the treatment of Schistosoma haematobium infection among schoolchildren in Al Salamania in Central Sudan. A cohort of schoolchildren (6-15 years of age) was investigated before and 1 year after treatment with a single dose of praziquantel 40mg/kg.
Sponsor: University of Khartoum
Current Primary Outcome: cure rate [ Time Frame: one year ]
Original Primary Outcome: Same as current
Current Secondary Outcome: reduction in the intensity of infection by [ Time Frame: one year ]
Original Secondary Outcome: Same as current
Information By: University of Khartoum
Dates:
Date Received: March 16, 2012
Date Started: August 2008
Date Completion:
Last Updated: January 16, 2013
Last Verified: January 2013